Associations between interleukin-10 polymorphisms and susceptibility to systemic lupus erythematosus: A meta-analysis

Human Immunology

Volumn 74, Issue 3, 2013, Pages 364-370

  Song, Gwan Gyu ^a   Choi, Sung Jae ^a   Ji, Jong Dae ^a   Lee, Young Ho ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ARTICLE; ASIAN; ETHNICITY; EUROPE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; META ANALYSIS (TOPIC); POPULATION GENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INTERLEUKIN-10; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84873705918     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.11.020     Document Type: Article

References (52)

1. Kang S.H., Chung B.H., Choi S.R., Lee J.Y., Park H.S., Sun I.O., et al. Comparison of clinical outcomes by different renal replacement therapy in patients with end-stage renal disease secondary to lupus nephritis. Korean J Intern Med 2011, 26:60-67.
2. Lee Y.H., Nath S.K. Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis. Hum Genet 2005, 118:434-443.
3. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001, 19:683-765.
4. Taga K., Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 1992, 148:1143-1148.
5. Eskdale J., Wordsworth P., Bowman S., Field M., Gallagher G. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens 1997, 49:635-639.
6. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogen 1997, 24:1-8.
7. Guzowski D., Chandrasekaran A., Gawel C., Palma J., Koenig J., Wang X.P., et al. Analysis of single nucleotide polymorphisms in the promoter region of interleukin-10 by denaturing high-performance liquid chromatography. J Biomol Tech 2005, 16:154-166.
8. Lopez P., Gutierrez C., Suarez A. IL-10 and TNFalpha genotypes in SLE. J Biomed Biotechnol 2010, 838390.
9. Lee Y.H., Bae S.C., Choi S.J., Ji J.D., Song G.G. Associations between interleukin-10 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis. Mol Biol Rep 2012, 39:81-87.
10. Lee Y.H., Choi S.J., Ji J.D., Song G.G. Associations between interleukin-10 polymorphisms and susceptibility to psoriasis: a meta-analysis. Inflamm Res 2012, 61:657-663. 10.1007/s00011-012-0458-2.
11. Nie W., Fang Z., Li B., Xiu Q.Y. Interleukin-10 promoter polymorphisms and asthma risk: a meta-analysis. Cytokine 2012, 60:849-855.
12. Makela M.J., Kanehiro A., Borish L., Dakhama A., Loader J., Joetham A., et al. IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization. Proc Natl Acad Sci USA 2000, 97:6007-6012.
13. Tarzi M., Klunker S., Texier C., Verhoef A., Stapel S.O., Akdis C.A., et al. Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy. Clin Exp Allergy 2006, 36:465-474.
14. Grondal G., Gunnarsson I., Ronnelid J., Rogberg S., Klareskog L., Lundberg I. Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 2000, 18:565-570.
15. Nath S.K., Harley J.B., Lee Y.H. Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis. Hum Genet 2005, 118:225-234.
16. Lin Y.J., Wan L., Huang C.M., Sheu J.J., Chen S.Y., Lin T.H., et al. IL-10 and TNF-alpha promoter polymorphisms in susceptibility to systemic lupus erythematosus in Taiwan. Clin Exp Rheumatol 2010, 28:318-324.
17. Sobkowiak A., Lianeri M., Wudarski M., Lacki J.K., Jagodzinski P.P. Genetic variation in the interleukin-10 gene promoter in Polish patients with systemic lupus erythematosus. Rheumatol Int 2009, 29:921-925.
18. Rosado S., Rua-Figueroa I., Vargas J.A., Garcia-Laorden M.I., Losada-Fernandez I., Martin-Donaire T., et al. Interleukin-10 promoter polymorphisms in patients with systemic lupus erythematosus from the Canary Islands. Int J Immunogenet 2008, 35:235-242.
19. Guarnizo-Zuccardi P., Lopez Y., Giraldo M., Garcia N., Rodriguez L., Ramirez L., et al. Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus. Tissue Antigens 2007, 70:376-382.
20. Hirankarn N., Wongpiyabovorn J., Hanvivatvong O., Netsawang J., Akkasilpa S., Wongchinsri J., et al. The synergistic effect of FC gamma receptor IIa and interleukin-10 genes on the risk to develop systemic lupus erythematosus in Thai population. Tissue Antigens 2006, 68:399-406.
21. Lin P.W., Huang C.M., Huang C.C., Tsai C.H., Tsai J.J., Chang C.P., et al. The association of -627 interleukin-10 promoter polymorphism in Chinese patients with systemic lupus erythematosus. Clin Rheumatol 2007, 26:298-301.
22. Zhu L.J., Liu Z.H., Zeng C.H., Chen Z.H., Yu C., Li L.S. Association of interleukin-10 gene -592 A/C polymorphism with the clinical and pathological diversity of lupus nephritis. Clin Exp Rheumatol 2005, 23:854-860.
23. Lu L.Y., Cheng H.H., Sung P.K., Tai M.H., Yeh J.J., Chen A. Tumor necrosis factor-beta +252A polymorphism is associated with systemic lupus erythematosus in Taiwan. J Formos Med Assoc 2005, 104:563-570.
24. Suarez A., Lopez P., Mozo L., Gutierrez C. Differential effect of IL10 and TNF{alpha} genotypes on determining susceptibility to discoid and systemic lupus erythematosus. Ann Rheum Dis 2005, 64:1605-1610.
25. Fei G.Z., Svenungsson E., Frostegard J., Padyukov L. The A-1087IL-10 allele is associated with cardiovascular disease in SLE. Atherosclerosis 2004, 177:409-414.
26. Chong W.P., Ip W.K., Wong W.H., Lau C.S., Chan T.M., Lau Y.L. Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus. Genes Immunol 2004, 5:484-492.
27. Khoa P.D., Sugiyama T., Yokochi T. Polymorphism of interleukin-10 promoter and tumor necrosis factor receptor II in vietnamese patients with systemic lupus erythematosus. Clin Rheumatol 2005, 24:11-13.
28. Dijstelbloem H.M., Hepkema B.G., Kallenberg C.G., van der Linden M.W., Keijsers V., Huizinga T.W., et al. The R-H polymorphism of FCgamma receptor IIa as a risk factor for systemic lupus erythematosus is independent of single-nucleotide polymorphisms in the interleukin-10 gene promoter. Arthritis Rheum 2002, 46:1125-1126.
29. Da S., Giordano M., Mellai M., Lanceni M., Barizzone N., Marchini M., et al. Association tests with systemic lupus erythematosus (SLE) of IL10 markers indicate a direct involvement of a CA repeat in the 5' regulatory region. Genes Immunol 2002, 3:454-463.
30. van der Linden M.W., Westendorp R.G., Sturk A., Bergman W., Huizinga T.W. High interleukin-10 production in first-degree relatives of patients with generalized but not cutaneous lupus erythematosus. J Invest Med 2000, 48:327-334.
31. Rood M.J., Keijsers V., van der Linden M.W., Tong T.Q., Borggreve S.E., Verweij C.L., et al. Neuropsychiatric systemic lupus erythematosus is associated with imbalance in interleukin 10 promoter haplotypes. Ann Rheum Dis 1999, 58:85-89.
32. Crawley E., Woo P., Isenberg D.A. Single nucleotide polymorphic haplotypes of the interleukin-10 5' flanking region are not associated with renal disease or serology in Caucasian patients with systemic lupus erythematosus. Arthritis Rheum 1999, 42:2017-2018.
33. Mok C.C., Lanchbury J.S., Chan D.W., Lau C.S. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 1998, 41:1090-1095.
34. Lazarus M., Hajeer A.H., Turner D., Sinnott P., Worthington J., Ollier W.E., et al. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol 1997, 24:2314-2317.
35. Lee Y.H., Rho Y.H., Choi S.J., Ji J.D., Song G.G. Association of TNF-alpha -308 G/A polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid arthritis: a meta-analysis. Rheumatol Int 2006, 27:157-161.
36. Choi S.J., Rho Y.H., Ji J.D., Song G.G., Lee Y.H. Genome scan meta-analysis of rheumatoid arthritis. Rheumatology (Oxford) 2006, 45:166-170.
37. Lee Y.H., Harley J.B., Nath S.K. Meta-analysis of TNF-alpha promoter -308 A/G polymorphism and SLE susceptibility. Eur J Hum Genet 2006, 14:364-371.
38. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
39. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
40. Egger M., Smith G.D., Phillips A.N. Meta-analysis: principles and procedures. BMJ 1997, 315:1533-1537.
41. DerSimonian R., Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986, 7:177-188.
42. Gateva V., Sandling J.K., Hom G., Taylor K.E., Chung S.A., Sun X., et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 2009, 41:1228-1233.
43. Hermann J., Gruber S., Neufeld J.B., Grundtner P., Graninger M., Graninger W.B., et al. IL10R1 loss-of-function alleles in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Rheumatol 2009, 27:603-608.
44. Miyagawa H., Yamai M., Sakaguchi D., Kiyohara C., Tsukamoto H., Kimoto Y., et al. Association of polymorphisms in complement component C3 gene with susceptibility to systemic lupus erythematosus. Rheumatology (Oxford) 2008, 47:158-164.
45. Xu Y., Chen Z.Q., Li Y.M., Gong J.Q., Li A.S., Chen M., et al. Correlation between some Th1 and Th2 cytokine receptor gene polymorphisms and systemic lupus erythematosus in Chinese patients. Int J Dermatol 2007, 46:1129-1135.
46. Lopez P., Gomez J., Mozo L., Gutierrez C., Suarez A. Cytokine polymorphisms influence treatment outcomes in SLE patients treated with antimalarial drugs. Arthritis Res Ther 2006, 8:R42.
47. Sung Y.K., Park B.L., Shin H.D., Kim L.H., Kim S.Y., Bae S.C. Interleukin-10 gene polymorphisms are associated with the SLICC/ACR Damage Index in systemic lupus erythematosus. Rheumatology (Oxford) 2006, 45:400-404.
48. Schotte H., Gaubitz M., Willeke P., Tidow N., Assmann G., Domschke W., et al. Interleukin-10 promoter microsatellite polymorphisms in systemic lupus erythematosus: association with the anti-Sm immune response. Rheumatology (Oxford) 2004, 43:1357-1363.
49. Mehrian R., Quismorio F.P., Strassmann G., Stimmler M.M., Horwitz D.A., Kitridou R.C., et al. Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus. Arthritis Rheum 1998, 41:596-602.
50. D'Alfonso S., Rampi M., Bocchio D., Colombo G., Scorza-Smeraldi R., Momigliano-Richardi P. Systemic lupus erythematosus candidate genes in the Italian population: evidence for a significant association with interleukin-10. Arthritis Rheum 2000, 43:120-128.
51. Alarcon-Riquelme M.E., Lindqvist A.K., Jonasson I., Johanneson B., Sandino S., Alcocer-Varela J., et al. Genetic analysis of the contribution of IL10 to systemic lupus erythematosus. J Rheumatol 1999, 26:2148-2152.
52. Gibson A.W., Edberg J.C., Wu J., Westendorp R.G., Huizinga T.W., Kimberly R.P. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 2001, 166:3915-3922.